China has approved its first mRNA vaccine after a long wait. On Wednesday, the Chinese company CSPC Pharmaceutical announced on the Hong Kong stock exchange that it had received emergency approval for its mRNA vaccine developed against the Omicron variant. The company, based in Shijiazhuang, Hebei province, did not initially provide details on when the vaccine would be used in Chinese vaccination centers and hospitals.
Continue reading now
… and get free access to this Professional Briefing for a month.
Are you already a guest at the China.Table? Log in now